Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI   US84763A1088

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
6.28(c) 6.22(c) 6.35(c) 6.19(c) 6.23 Last
8 172 935 1 617 194 2 072 737 2 172 130 1 671 314 Volume
-15.82% -0.96% +2.09% -2.52% +0.65% Change
More quotes
Company
Spectrum Pharmaceuticals, Inc. is a biotechnology company with fully integrated commercial and drug development operations, with a primary focus in hematology and oncology.It operates through one segment: acquiring, developing and commercializing prescription drug products.The company markets two... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 184 M
EBIT 2014 -37,3 M
Net income 2014 -49,2 M
Debt 2014 -
Yield 2014 -
Sales 2015 184 M
EBIT 2015 -14,8 M
Net income 2015 -23,0 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 2,22x
Capi. / Sales 2015 2,22x
Capitalization 408 M
More Financials
Latest news on SPECTRUM PHARMACEUTICALS,
02/25 SPECTRUM PHARMACEUTICALS : Patent Issued for Sensitization of Tumor Cells to Rad..
02/25 SPECTRUM PHARMACEUTICALS : Market Updates on Biotech Stocks - Hemispherx Biophar..
02/23 SPECTRUM PHARMACEUTICALS : Nasdaq stocks posting largest percentage decreases
02/23 SPECTRUM PHARMACEUTICALS : Regulation FD Disclosure (form 8-K)
02/21 SPECTRUM PHARMACEUTICALS : Reviews Clinical Data for Captisol-Enabled Melphalan ..
02/21 SPECTRUM PHARMACEUTICALS : Sets Fourth Quarter 2014 Financial Results and Analys..
02/20 SPECTRUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
02/20 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the 2015 RBC Capital M..
More news
Sector news Biotechnology & Medical Research - NEC
02:46p PHARMACYCLICS : Provides Clinical Update on BTK Inhibitor for Autoimmune Disease..
10:25a ISIS PHARMACEUTICALS : beats Street 4Q forecasts
09:44a ISIS PHARMACEUTICALS : Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx P..
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF